Victoria Blinder

Economics, Econometrics and FinanceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.104Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Quality of treatment selection for Medicare beneficiaries with cancer.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.140

Top 78%

0.104DataRank

Top 78%1 citations

Aaron Philip Mitchell, Akriti Mishra Meza, Hannah E. Fuchs, Sara Tabatabai, Nirjhar Chakraborty +11 more

Papers

Driven by 33 papers — median percentile 22. Top paper: “Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study”.

Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0855

N/A

2.2DataRank · unranked

68 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

An interactive mobile application versus an educational booklet to promote job retention in women undergoing adjuvant chemotherapy for breast cancer: a randomized controlled trial

Trials(2022)10.1186/s13063-022-06580-7

N/A

0.965DataRank · unranked

15 citations

Sujata Patil, Jackie Finik, Della Makower, Monica Reddy Muppidi, Wendy G. Lichtenthal +6 more

Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients with Residual HER2-Positive Invasive Breast Cancer

Future Oncology(2021)10.2217/fon-2021-0753

N/A

0.901DataRank · unranked

30 citations

Karla V. Ballman, Linda McCall, Anuhya Kommalapati, Tyler Zemla, Anna Weiss +12 more

The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07433-4

N/A

0.359DataRank · unranked

7 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +18 more

Quality of treatment selection for Medicare beneficiaries with cancer.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.140

Top 78%

0.104DataRank

Top 78%1 citations

Aaron Philip Mitchell, Akriti Mishra Meza, Hannah E. Fuchs, Sara Tabatabai, Nirjhar Chakraborty +11 more

Risk factors for financial toxicity in patients with gynecologic cancer

American Journal of Obstetrics and Gynecology(2021)10.1016/j.ajog.2021.12.012

N/A

0DataRank · unranked

55 citations

Beryl Manning‐Geist, Stefania Sokolowski, Tiffanny Newman, Victoria Blinder, Fumiko Chino +15 more

Breast Cancer–Related Employment Disruption and Financial Hardship in the Sister Study

JNCI Cancer Spectrum(2021)10.1093/jncics/pkab024

N/A

0DataRank · unranked

32 citations

Dale P. Sandler, Lucy A. Peipins, M. Elizabeth Hodgson, Victoria Blinder, Stephanie B. Wheeler +2 more

Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06153-3

N/A

0DataRank · unranked

41 citations

Megan E. Gregory, J.G. Bazan, Maryam B. Lustberg, Shoshana M. Rosenberg, Victoria Blinder +6 more

Racial and ethnic disparities among patients with breast cancer and COVID-19.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6500

N/A

0DataRank · unranked

0 citations

Melissa Accordino, Benjamin French, Nicole M. Kuderer, Gary H. Lyman, Daniel G. Stover +14 more

Cancer-Related Care Costs and Employment Disruption: Recommendations to Reduce Patient Economic Burden as Part of Cancer Care Delivery

JNCI Monographs(2022)10.1093/jncimonographs/lgac006

N/A

0DataRank · unranked

27 citations

Courtney Williams, Victoria Blinder, Janet S. de Moor

Work Status Reduction and Cost-Related Nonadherence during Cancer Treatment

Health & Social Work(2022)10.1093/hsw/hlac004

N/A

0DataRank · unranked

8 citations

Jackie Finik, Victoria Blinder, Meredith Doherty

Lymphedema therapy referral is associated with improved understanding of lymphedema prevention among breast cancer survivors

Research Square(2022)10.21203/rs.3.rs-1941994/v1

N/A

0DataRank · unranked

1 citations

Kathryn R. Tringale, Sujata Patil, Giacomo Montagna, Jackie Finik, Ting-Ting Kuo +6 more

Use of quality-of-life-related (QoL) eHealth interventions with Latino cancer patients during the pandemic: Findings from Latin America, United States, and Spain.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e18542

N/A

0DataRank · unranked

0 citations

Cristiane Decat Bergerot, Eida Castro, Óscar Galindo, Fernanda Montaña, L. Esenarro +7 more

Lymphedema therapy referral is associated with improved understanding of lymphedema prevention among breast cancer survivors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12069

N/A

0DataRank · unranked

0 citations

Sujata Patil, Jackie Finik, Ting-Ting Kuo, Carolyn Eberle, Alexandr Pinkhasov +4 more

Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07127-3

N/A

0DataRank · unranked

1 citations

Edi Brogi, Donna M. Thompson, Victoria Blinder, Larry Norton, Monica Morrow +3 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578.v1

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Patient-reported usefulness of an intervention to promote job retention among women undergoing (neo)adjuvant breast cancer chemotherapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1586

N/A

0DataRank · unranked

0 citations

Jackie Finik, Sujata Patil, Bharat Narang, Maria Claros, Jennifer Suarez +7 more

Impact of workplace accommodations on long-term work outcomes in a diverse sample of breast cancer survivors.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.501

N/A

0DataRank · unranked

0 citations

Jackie Finik, Minlun Wu, Maria Claros, Jennifer Suarez, Bharat Narang +3 more

Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)

Quality of Life Research(2024)10.1007/s11136-024-03675-3

N/A

0DataRank · unranked

17 citations

Amylou C. Dueck, Brenda Ginos, Jennifer Jansen, Allison M. Deal, Philip Carr +9 more

Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I–IIIA breast cancer

International Journal of Cancer(2024)10.1002/ijc.35053

N/A

0DataRank · unranked

4 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +19 more

Measuring Self‐Efficacy to Request Cancer‐Related Work Accommodations: Development and Validation of a Brief Survey Instrument

Psycho-Oncology(2024)10.1002/pon.70028

N/A

0DataRank · unranked

2 citations

Jada G. Hamilton, Carolyn Eberle, Jackie Finik, Bharat Narang, Rose C. Maly +3 more

Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-24-0360

N/A

0DataRank · unranked

2 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael P. Burganowski-Doud, Isaac J. Ergas +18 more

Breast Cancer-Related Employment Disruption and Financial Hardship in the Sister Study

UNC Libraries(2024)10.17615/419y-r798

N/A

0DataRank · unranked

0 citations

Stephanie B. Wheeler, M.E Hodgson, Hazel B. Nichols, Victoria Blinder, Lucy A. Peipins +2 more

Provider and facility factors in relation to receipt of dose-reduced chemotherapy among patients with breast cancer.

JCO Oncology Practice(2024)10.1200/op.2024.20.10_suppl.310

N/A

0DataRank · unranked

0 citations

Kelli O’Connell, Jenna Bhimani, Victoria Blinder, Rachael Doud, Grace Gallagher +15 more

Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00833-9

N/A

0DataRank · unranked

1 citations

Kelli O’Connell, Grace B Gallagher, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +19 more

Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf314

N/A

0DataRank · unranked

1 citations

Kelli O’Connell, Jenna Bhimani, Grace Gallagher, Victoria Blinder, Rachael Doud +19 more

ACR Appropriateness Criteria® Imaging of Ductal Carcinoma in Situ (DCIS)

Journal of the American College of Radiology(2025)10.1016/j.jacr.2025.02.027

N/A

0DataRank · unranked

0 citations

Richard E. Sharpe, Alana A. Lewin, Susan P. Weinstein, Victoria Blinder, Elizabeth H. Dibble +9 more

Evaluation of methods to identify chemotherapy‐related hematologic toxicities in real‐world settings

International Journal of Cancer(2025)10.1002/ijc.70266

N/A

0DataRank · unranked

0 citations

Kelli O’Connell, Jenna Bhimani, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +20 more

Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa048

N/A

0DataRank · unranked

64 citations

Wanqing Iris Zhi, Raymond E. Baser, Madeline J. Hooper, Connie Chen, Lauren Piulson +8 more

Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05726-y

N/A

0DataRank · unranked

37 citations

Dulce M. Barrios, Victoria Blinder, Jacqueline Bromberg, Pamela Drullinsky, Samuel A. Funt +10 more

Use of patient-reported controls for secular trends to study disparities in cancer-related job loss

Journal of Cancer Survivorship(2020)10.1007/s11764-020-00960-1

N/A

0DataRank · unranked

5 citations

Carolyn Eberle, Christina Tran, Ting Bao, Manmeet Malik, Gabriel Jung +5 more

Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1063

N/A

0DataRank · unranked

4 citations

Diana G. Wang, Victoria Blinder, Jacqueline Bromberg, Pamela Drullinsky, Samuel A. Funt +10 more

Victoria Blinder

Indexed papers

Top data-sharing exemplar

Papers